The firefly luciferase reporter plasmid, pABM2 (pGAL4-M2-Luc), with five GAL4-binding sites 36 base pairs upstream of the adenovirus major late TATA box and with a downstream region taken from the retinoic acid receptor  2 promoter [3] [4] , was a gift from Dr. Mark S. Ptashne. The plasmid constitutively expressing the Renilla luciferase pHRL-TK (GenBank Acc. No. AF362549.1) from Promega (Madison, WI, USA) was used to normalize the level of the transfection in the experiments that used the firefly luciferase as a reporter gene.
The effector gene construct pABM2(IFN-1), which contained five GAL4-binding sites and gene for human IFN-1, was prepared from the firefly luciferase reporter plasmid pABM2; we replaced the gene for the firefly luciferase with the gene for human IFN-1 (NM_002176; Cat. No. SC127861, OriGene Technologies, Inc.) with a hexa-histidine tag at its C-terminus.
The HIV-1 protease inhibitors saquinavir, atazanavir, and ritonavir, were dissolved in dimethyl sulfoxide (DMSO) and used in the culture medium at final concentrations of 1 μM or 5 μM. The DMSO at a final concentration of 0.1% was added to the control cultures. Legend: CD4, the whole sequence of the human CD4; HA, HA affinity tag; hivp, HIV-1 protease cleavage site; GAL4, 2-147 amino acids of Gal4; VP16, 413-490 amino acids of VP16; italic letters indicate unspecific sequences; amino acid sequence is shaded gray. 
